HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Béatrice Mahé Selected Research
Béatrice Mahé Research Topics
Disease
5
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
06/2022 - 01/2017
5
Multiple Myeloma
01/2021 - 11/2011
4
Neoplasms (Cancer)
01/2024 - 12/2008
4
Waldenstrom Macroglobulinemia (Macroglobulinemia)
10/2023 - 11/2011
4
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2021 - 09/2005
2
Graft vs Host Disease (Graft-Versus-Host Disease)
01/2024 - 04/2021
2
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 01/2019
2
Lymphoma (Lymphomas)
01/2021 - 01/2019
1
Pathologic Complete Response
01/2023
1
Disease Progression
06/2019
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2019
1
Hodgkin Disease (Hodgkin's Disease)
01/2019
1
Leukemia
01/2019
1
Neutropenia
02/2018
1
Infections
02/2018
1
Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
08/2012
1
Monoclonal Gammopathy of Undetermined Significance
11/2011
1
Hemorrhage
11/2011
1
Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
12/2008
1
Myelodysplastic Syndromes (Myelodysplastic Syndrome)
01/2008
1
Zygomycosis (Phycomycosis)
02/2005
1
Hematologic Diseases (Blood Diseases)
02/2005
Drug/Important Bio-Agent (IBA)
9
Rituximab (Mabthera)
FDA Link
10/2023 - 12/2008
6
Cyclophosphamide (Cytoxan)
FDA Link
Generic
10/2023 - 01/2018
3
Dexamethasone (Maxidex)
FDA Link
Generic
10/2023 - 11/2017
3
fludarabine
IBA
01/2023 - 01/2018
2
Bortezomib (Velcade)
FDA Link
10/2023 - 11/2017
2
obinutuzumab
IBA
01/2023 - 11/2021
2
Proteasome Inhibitors
IBA
06/2019 - 06/2019
2
Monoclonal Antibodies
IBA
06/2019 - 12/2008
2
flt3 ligand protein (flt3 ligand)
IBA
01/2019 - 01/2019
1
Interleukin-2 (IL2)
IBA
01/2024
1
Zoledronic Acid (Zometa)
FDA Link
01/2024
1
ibrutinib
IBA
01/2023
1
idelalisib
IBA
11/2021
1
Ligands
IBA
01/2021
1
KIR Receptors
IBA
01/2021
1
Cytokines
IBA
01/2021
1
dabrafenib
IBA
07/2020
1
trametinib
IBA
07/2020
1
Lenalidomide (CC 5013)
FDA Link
06/2019
1
daratumumab
IBA
06/2019
1
pomalidomide
IBA
06/2019
1
Fluorine-18
IBA
01/2019
1
Alemtuzumab (Campath)
FDA Link
01/2018
1
Hemoglobins (Hemoglobin)
IBA
08/2012
1
Immunoglobulin G (IgG)
IBA
11/2011
1
Immunoglobulin A (IgA)
IBA
11/2011
1
von Willebrand Factor
IBA
11/2011
1
Immunoglobulin M (IgM)
IBA
11/2011
1
Hemostatics (Antihemorrhagics)
IBA
11/2011
1
Factor VIII (Coagulation Factor VIII)
IBA
11/2011
1
Interferons
IBA
12/2008
1
Granulocyte Colony-Stimulating Factor (G-CSF)
IBA
01/2008
1
epoetin beta
IBA
01/2008
1
Erythropoietin
FDA Link
01/2008
1
Mitoxantrone (Novantrone)
FDA Link
Generic
09/2005
1
Gemtuzumab (Mylotarg)
FDA Link
09/2005
1
Voriconazole (Vfend)
FDA Link
Generic
02/2005
Therapy/Procedure
5
Therapeutics
06/2022 - 06/2019
3
Drug Therapy (Chemotherapy)
10/2023 - 09/2005
1
Immunotherapy
01/2021
1
Homologous Transplantation
01/2019
1
Hematopoietic Stem Cell Transplantation
01/2019
1
Stem Cell Transplantation
01/2019